|
|
CD45RO Antibody (clone UCHL1, PE) LS‑C46533
CD45RO antibody LS-C46533 is a PE-conjugated mouse monoclonal antibody to human CD45RO. Validated for Flow.
Print This Page
Technical Help
Review This ProductPopular CD45RO Products
Species:
Human
Applications:
IHC, IHC - Paraffin, IHC - Frozen, Immunoprecipitation, Flow Cytometry
Species:
Human
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Flow Cytometry
Product Description
CD45RO antibody LS-C46533 is a PE-conjugated mouse monoclonal antibody to human CD45RO. Validated for Flow.
About CD45RO
Protein tyrosine phosphatase, receptor type, C also known as PTPRC is an enzyme that, in humans, is encoded by the PTPRC gene. PTPRC is also known as CD45 antigen (CD stands for cluster of differentiation), which was originally called leukocyte common antigen (LCA). The CD45 family consists of multiple members that are all products of a single complex gene.
Specifications
Target
Human CD45RO
Host
Mouse
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG2a
Monoclonal
[UCHL1]
Conjugations
Phycoerythrin
Purification
Purified
Modifications
Unmodified
Applications
- Flow Cytometry
Immunogen
CD45RO antibody was raised against human IL-2 dependent T cells.
Specificity
Recognizes CD45R0, a 180 kD low molecular weight isoform of the leukocyte common antigen (LCA). The antigen is expressed on a subset of memory/activated T cells and on cortical thymocytes.
Usage
The reagent is designed for Flow Cytometry analysis of human blood cells using 20 ul reagent / 100 ul of whole blood or 106 cells in a suspension. The content of a vial (2 ml) is sufficient for 100 tests. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
Presentation
PBS, 15 mM sodium azide, 0.2% high-grade protease free BSA as a stabilizing agent.
Restrictions
For research use only.
Guarantee
This antibody carries the LSBio 100% Guarantee.
Publications (0)
Customer Reviews (0)
Requested From:
Date Requested: 6/20/2018
Date Requested: 6/20/2018
